Peterson Wealth Services’s AstraZeneca AZN Stock Holding History

Peterson Wealth Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-42	Closed	-$7.96K	–	227
2026 Q2	$7.96K	Buy	+42	New	+$7.9K	﹤0.01%	191

Other funds holding AZN

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $162B AUM

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Peterson Wealth Services's AZN Position: Q3 2026 in Review

Peterson Wealth Services sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 42 shares — an estimated $7.96K sold.

Peterson Wealth Services first reported a position in AZN in Q2 2026 and held it in 1 quarter. The position peaked at $7.96K in Q2 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Peterson Wealth Services reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
Peterson Wealth Services sold 42 AstraZeneca shares in Q3 2026, an estimated $7.96K.
Peterson Wealth Services first reported a position in AstraZeneca in Q2 2026 and held it in 1 quarter.
Peterson Wealth Services's AstraZeneca position peaked at $7.96K in Q2 2026.
1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Peterson Wealth Services's 13F filing for Q3 2026, filed 26 Oct 2026.